Skip to content

Transfusion of fresh frozen plasma in non bleeding ICU patients

Transfusion of fresh frozen plasma in non bleeding ICU patients - TOPIC trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38043
Enrollment
400
Registered
2010-05-11
Start date
2010-05-25
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coagulopathy impaired clotting

Interventions

Intervention: omitting prophylactic transfusion of a fixed dose of 12 ml/kg of FFP prior to an invasive procedure compared to transfusion of a fixed dose of FFP of 12 ml/kg.

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -18 years and older -INR >1.5 and

Exclusion criteria

Exclusion criteria: - clinically overt bleeding at the time of the procedure (excludes minor epistaxis, minor gum bleeding, microscopic hematuria, superficial bruises, or normal menses) - thrombocytopenia of

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study will be a procedure-related relevant bleeding, occurring within 24 hours after the procedure. Relevant bleeding will be defined using a validated tool for assessment of bleeding in the critically ill by: overt bleeding with anyone of the following: -a decrease in haemoglobin by more then 20 g/l in the absence of another cause -transfusion 2 or more units red cells without an increase in haemoglobin -a decrease in systolic blood pressure by more then 20 mmHg -an increase in heart rate of 20 beats/min, -bleeding at a wound site requiring an intervention (for example, re-operation). An assessment of bleeding will be standardized and performed by an independent research physician or intensivist blinded to the transfusion strategy 1 and 24 hours after the procedure and when clinically indicated. The assessment will consist of a physical examination, inspection of chest drain production. Also, haemoglobin will be measured at 1 and 24 hours after the procedure and when clinically indicated. A chest radiograph will be made to capture intra-thoracic bleeding. Hemodynamic parameters (blood pressure and heart rate) will be recorded by an electronic patient data monitoring system.

Secondary

MeasureTime frame
Secondary outcomes: - minor bleeding within 24 hours - onset of acute lung injury within 48 hours. - correction of INR to

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)